Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Experimental Nephrology
Published in: Clinical and Experimental Nephrology 2/2005

01-06-2005 | ORIGINAL ARTICLE

Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy

Authors: Norihiko Goto, Yoshihiro Tominaga, Susumu Matsuoka, Tetsuhiko Sato, Akio Katayama, Toshihito Haba, Kazuharu Uchida

Published in: Clinical and Experimental Nephrology | Issue 2/2005

Login to get access
Metadata
Title
Cardiovascular complications caused by advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy
Authors
Norihiko Goto
Yoshihiro Tominaga
Susumu Matsuoka
Tetsuhiko Sato
Akio Katayama
Toshihito Haba
Kazuharu Uchida
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
Clinical and Experimental Nephrology / Issue 2/2005
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-005-0351-1

Other articles of this Issue 2/2005

Clinical and Experimental Nephrology 2/2005 Go to the issue

ORIGINAL ARTICLE

Effects of low dialysate calcium concentration on health-related quality of life in hemodialysis patients

CASE REPORT

ANCA-negative pauci-immune crescentic glomerulonephritis complicated with recurrent massive gastrointestinal hemorrhage

ORIGINAL ARTICLE

Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-β produced by tubular epithelial cells in response to high glucose

ORIGINAL ARTICLE

High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis

CASE REPORT

Tuberous sclerosis, associated with renal cell carcinoma and angiomyolipoma, in a patient who developed endstage renal failure after nephrectomy

REVIEW ARTICLE

Renal tubular transport and the genetic basis of hypertensive disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits